These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

370 related items for PubMed ID: 29373227

  • 1. Outcome of Acute Ischemic Stroke after the Treatment with Edaravone and 0.6 Mg/Kg Alteplase in Japanese Patients with Diabetes.
    Tanahashi N, Yamaguchi T, Awano H, Matsuda H.
    J Stroke Cerebrovasc Dis; 2018 May; 27(5):1302-1310. PubMed ID: 29373227
    [Abstract] [Full Text] [Related]

  • 2. Edaravone with and without .6 Mg/Kg Alteplase within 4.5 Hours after Ischemic Stroke: A Prospective Cohort Study (PROTECT4.5).
    Yamaguchi T, Awano H, Matsuda H, Tanahashi N, PROTECT4.5 Investigators.
    J Stroke Cerebrovasc Dis; 2017 Apr; 26(4):756-765. PubMed ID: 27887792
    [Abstract] [Full Text] [Related]

  • 3. Intravenous thrombolysis with neuroprotective therapy by edaravone for ischemic stroke patients older than 80 years of age.
    Kono S, Deguchi K, Morimoto N, Kurata T, Yamashita T, Ikeda Y, Narai H, Manabe Y, Takao Y, Kawada S, Kashihara K, Takehisa Y, Inoue S, Kiriyama H, Abe K.
    J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):1175-83. PubMed ID: 23507462
    [Abstract] [Full Text] [Related]

  • 4. Effects of edaravone, a free radical scavenger, on circulating levels of MMP-9 and hemorrhagic transformation in patients with intravenous thrombolysis using low-dose alteplase.
    Tsuruoka A, Atsumi C, Mizukami H, Imai T, Hagiwara Y, Hasegawa Y.
    J Stroke Cerebrovasc Dis; 2014 Oct; 23(10):2894-2899. PubMed ID: 25282183
    [Abstract] [Full Text] [Related]

  • 5. Tissue plasminogen activator thrombolytic therapy for acute ischemic stroke in 4 hospital groups in Japan.
    Kono S, Deguchi K, Morimoto N, Kurata T, Deguchi S, Yamashita T, Ikeda Y, Matsuura T, Narai H, Omori N, Manabe Y, Yunoki T, Takao Y, Kawata S, Kashihara K, Abe K.
    J Stroke Cerebrovasc Dis; 2013 Apr; 22(3):190-6. PubMed ID: 21968092
    [Abstract] [Full Text] [Related]

  • 6. Outcome of stroke patients receiving different doses of recombinant tissue plasminogen activator.
    Ong CT, Wong YS, Wu CS, Su YH.
    Drug Des Devel Ther; 2017 Apr; 11():1559-1566. PubMed ID: 28572721
    [Abstract] [Full Text] [Related]

  • 7. Low-Dose Tissue Plasminogen Activator in Acute Ischemic Stroke: A Systematic Review and Meta-Analysis.
    Cheng JW, Zhang XJ, Cheng LS, Li GY, Zhang LJ, Ji KX, Zhao Q, Bai Y.
    J Stroke Cerebrovasc Dis; 2018 Feb; 27(2):381-390. PubMed ID: 29111341
    [Abstract] [Full Text] [Related]

  • 8. Impact of Tissue Plasminogen Activator Dosing on Patients Weighing More Than 100 kg on 3-Month Outcomes in Acute Ischemic Stroke.
    Garavaglia J, Sherman J, Yetzer H, Regier M, Smith M.
    J Stroke Cerebrovasc Dis; 2017 May; 26(5):1041-1046. PubMed ID: 28129994
    [Abstract] [Full Text] [Related]

  • 9. Acute kidney injury and edaravone in acute ischemic stroke: the Fukuoka Stroke Registry.
    Kamouchi M, Sakai H, Kiyohara Y, Minematsu K, Hayashi K, Kitazono T.
    J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):e470-6. PubMed ID: 23800495
    [Abstract] [Full Text] [Related]

  • 10. Very Early versus Delayed Rehabilitation for Acute Ischemic Stroke Patients with Intravenous Recombinant Tissue Plasminogen Activator: A Nationwide Retrospective Cohort Study.
    Momosaki R, Yasunaga H, Kakuda W, Matsui H, Fushimi K, Abo M.
    Cerebrovasc Dis; 2016 Nov; 42(1-2):41-8. PubMed ID: 26986718
    [Abstract] [Full Text] [Related]

  • 11. Correlation of Changes in Leukocytes Levels 24 Hours after Intravenous Thrombolysis With Prognosis in Patients With Acute Ischemic Stroke.
    Chen J, Zhang Z, Chen L, Feng X, Hu W, Ge W, Li X, Jin P, Shao B.
    J Stroke Cerebrovasc Dis; 2018 Oct; 27(10):2857-2862. PubMed ID: 30064868
    [Abstract] [Full Text] [Related]

  • 12. Simultaneous administration of recombinant tissue plasminogen activator and edaravone in acute cerebral ischemic stroke patients.
    Takenaka K, Kato M, Yamauti K, Hayashi K.
    J Stroke Cerebrovasc Dis; 2014 Oct; 23(10):2748-2752. PubMed ID: 25307430
    [Abstract] [Full Text] [Related]

  • 13. Effects of edaravone on early outcomes in acute ischemic stroke patients treated with recombinant tissue plasminogen activator.
    Wada T, Yasunaga H, Inokuchi R, Horiguchi H, Fushimi K, Matsubara T, Nakajima S, Yahagi N.
    J Neurol Sci; 2014 Oct 15; 345(1-2):106-11. PubMed ID: 25085762
    [Abstract] [Full Text] [Related]

  • 14. Stroke in a child safely treated with intravenous tissue plasminogen activator and edaravone, a free radical scavenger.
    Baba H, Sugimori H, Nanishi E, Nagata H, Lee S, Kuwashiro T, Hashizume M.
    J Stroke Cerebrovasc Dis; 2012 Nov 15; 21(8):903.e5-8. PubMed ID: 21421331
    [Abstract] [Full Text] [Related]

  • 15. Multicenter Study of Intravenous Recombinant Tissue Plasminogen Activator Infusion around Hiroshima, Japan: The Hiroshima Acute Stroke Retrospective and Prospective Registry Study.
    Aoki S, Hosomi N, Sueda Y, Kono T, Takamatsu K, Ohyama H, Torii T, Kitamura T, Nomura E, Noda K, Ohtsuki T, Matsumoto M, HARP Registry Study Group.
    J Stroke Cerebrovasc Dis; 2015 Dec 15; 24(12):2747-53. PubMed ID: 26360972
    [Abstract] [Full Text] [Related]

  • 16. Intravenous Tissue Plasminogen Activator for Wake-Up Stroke: A Propensity Score-Matched Analysis.
    Anaissie JE, Monlezun DJ, Siegler JE, Waring ED, Dowell LN, Samai AA, George AJ, Kimbrough T, Berthaud J, Martin-Schild S.
    J Stroke Cerebrovasc Dis; 2016 Nov 15; 25(11):2603-2609. PubMed ID: 27476340
    [Abstract] [Full Text] [Related]

  • 17. Outcomes of Nonagenarians with Acute Ischemic Stroke Treated with Intravenous Thrombolytics.
    Behrouz R, Masjuán-Vallejo J, Vera R, Willey JZ, Zedet M, Moulin S, Cordonnier C, Klijn CJM, Kanselaar K, Dirks M, Silver B, Khan M, Azarpazhooh MR, Godoy DA, Roffe C, Paley L, Bray BD, Smith CJ, Di Napoli M, ITAS-90+ Collaborative.
    J Stroke Cerebrovasc Dis; 2018 Jan 15; 27(1):246-256. PubMed ID: 28935502
    [Abstract] [Full Text] [Related]

  • 18. Effect of edaravone on the estimated glomerular filtration rate in patients with acute ischemic stroke and chronic kidney disease.
    Tsukamoto Y, Takizawa S, Takahashi W, Mase H, Miyachi H, Miyata T, Takagi S.
    J Stroke Cerebrovasc Dis; 2011 Jan 15; 20(2):111-6. PubMed ID: 20580255
    [Abstract] [Full Text] [Related]

  • 19. High Plasma D-Dimer Indicates Unfavorable Outcome of Acute Ischemic Stroke Patients Receiving Intravenous Thrombolysis.
    Hsu PJ, Chen CH, Yeh SJ, Tsai LK, Tang SC, Jeng JS.
    Cerebrovasc Dis; 2016 Jan 15; 42(1-2):117-21. PubMed ID: 27088493
    [Abstract] [Full Text] [Related]

  • 20. Temporal trends in patient characteristics and treatment with intravenous thrombolysis among acute ischemic stroke patients at Get With The Guidelines-Stroke hospitals.
    Schwamm LH, Ali SF, Reeves MJ, Smith EE, Saver JL, Messe S, Bhatt DL, Grau-Sepulveda MV, Peterson ED, Fonarow GC.
    Circ Cardiovasc Qual Outcomes; 2013 Sep 01; 6(5):543-9. PubMed ID: 24046398
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.